ulipristal acetate has been researched along with Leiomyosarcoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borja De Mozota, D; Kadhel, P; Smail, M | 1 |
| Biglia, N; D'alonzo, M; Garbagnati, M; Menato, G; Modaffari, P; Pecchio, S | 1 |
| Angelico, G; Arciuolo, D; Fanfani, F; Inzani, F; Romualdi, D; Santoro, A; Scambia, G; Zannoni, GF | 1 |
| Istre, O | 1 |
1 review(s) available for ulipristal acetate and Leiomyosarcoma
| Article | Year |
|---|---|
Unexpected uterine leiomyosarcoma in a woman with multiple myomas treated with ulipristal acetate: case report and literature review.
Topics: Female; Humans; Leiomyomatosis; Leiomyosarcoma; Middle Aged; Norpregnadienes; Uterine Neoplasms | 2018 |
3 other study(ies) available for ulipristal acetate and Leiomyosarcoma
| Article | Year |
|---|---|
Inefficiency of ulipristal acetate on uterus leiomyomas as an additional sign to suspect leiomyosarcoma.
Topics: Adult; Combined Modality Therapy; Diagnosis, Differential; Drug Resistance, Neoplasm; Female; Humans; Hysterectomy; Leiomyoma; Leiomyosarcoma; Morcellation; Norpregnadienes; Preoperative Care; Treatment Failure; Tumor Burden; Uterine Neoplasms | 2017 |
Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports.
Topics: Diagnosis, Differential; Female; Humans; Leiomyoma; Leiomyosarcoma; Middle Aged; Morcellation; Norpregnadienes; Uterine Myomectomy; Uterine Neoplasms | 2018 |
Unexpected Uterine Leiomyosarcoma During Laparoscopic Hysterectomy Treated 6 Months With Ulipristal Acetate and Contained Power Morcellation.
Topics: Delayed Diagnosis; Denmark; Disease Progression; Female; Humans; Hysterectomy; Intraoperative Period; Laparoscopy; Leiomyoma; Leiomyosarcoma; Lung Neoplasms; Menorrhagia; Middle Aged; Minimally Invasive Surgical Procedures; Morcellation; Norpregnadienes; Uterine Neoplasms | 2017 |